178 related articles for article (PubMed ID: 31295255)
21. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
[TBL] [Abstract][Full Text] [Related]
22. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
23. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
24. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
25. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
[TBL] [Abstract][Full Text] [Related]
26. Bacterial factors influencing the mortality for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
Zarakolu P; Metan G; Ünal S; Karahan ZC; Tekeli A
Infect Dis (Lond); 2016 Aug; 48(8):649-50. PubMed ID: 27167630
[No Abstract] [Full Text] [Related]
27. Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.
Guillamet MCV; Vazquez R; Deaton B; Shroba J; Vazquez L; Mercier RC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203479
[TBL] [Abstract][Full Text] [Related]
28. Impact of Community-Onset Methicillin-Resistant
Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN
Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778
[TBL] [Abstract][Full Text] [Related]
29. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Sakoulas G; Olson J; Yim J; Singh NB; Kumaraswamy M; Quach DT; Rybak MJ; Pogliano J; Nizet V
Antimicrob Agents Chemother; 2016 Nov; 60(11):6609-6618. PubMed ID: 27572414
[TBL] [Abstract][Full Text] [Related]
30. Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.
Seidl K; Bayer AS; Fowler VG; McKinnell JA; Abdel Hady W; Sakoulas G; Yeaman MR; Xiong YQ
Antimicrob Agents Chemother; 2011 Feb; 55(2):575-82. PubMed ID: 21098242
[TBL] [Abstract][Full Text] [Related]
31. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).
Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT
Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Staphylococcal Toxins and Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Maeda M; Shoji H; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Niki Y; Ishino K
Biol Pharm Bull; 2016; 39(7):1195-200. PubMed ID: 27374293
[TBL] [Abstract][Full Text] [Related]
33. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
34. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
35. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
36. Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia.
Kim NH; Kang YM; Han WD; Park KU; Park KH; Yoo JI; Lee DG; Park C; Song KH; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
Microb Drug Resist; 2016 Oct; 22(7):538-544. PubMed ID: 26982169
[TBL] [Abstract][Full Text] [Related]
37. Influence of antimicrobial regimen on decreased in-hospital mortality of patients with MRSA bacteremia.
Kaku N; Yanagihara K; Morinaga Y; Yamada K; Harada Y; Migiyama Y; Nagaoka K; Matsuda J; Uno N; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Yamamoto Y; Kohno S
J Infect Chemother; 2014 Jun; 20(6):350-5. PubMed ID: 24731430
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Barber KE; Rybak MJ; Sakoulas G
J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
[No Abstract] [Full Text] [Related]
39. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
40. Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis.
Goudarzi M; Seyedjavadi SS; Nasiri MJ; Goudarzi H; Sajadi Nia R; Dabiri H
Microb Pathog; 2017 Mar; 104():328-335. PubMed ID: 28159661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
